Unimeda - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,029,435 | 915,917 | 945,975 | 1,365,190 | 1,466,072 | 1,133,590 | 977,142 | 944,378 |
| Profit before tax | 8,531 | 8,894 | 58,541 | 167,189 | 176,110 | 110,005 | 30,292 | -20,888 |
| Net profit | 8,261 | 8,471 | 49,760 | 141,967 | 149,449 | 93,364 | 25,643 | -20,888 |
| Equity | 36,536 | 45,006 | 94,766 | 208,791 | 287,651 | 310,427 | 280,776 | 234,462 |
| Liabilities | 157,824 | 104,098 | 88,469 | 85,877 | 79,036 | 38,204 | 7,587 | 24,820 |
| Non-current assets | 12,741 | 8,462 | 4,183 | 32,011 | 24,019 | 6,203 | 63,384 | 62,104 |
| Current assets | 181,619 | 140,642 | 179,052 | 262,657 | 342,668 | 342,428 | 224,979 | 197,178 |
| Total assets | 194,360 | 149,104 | 183,235 | 294,668 | 366,687 | 348,631 | 288,363 | 259,282 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 243,721 | 186,423 | 170,546 |
| Social insurance contributions | - | - | - | - | - | 93,107 | 96,561 | 97,934 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +29.7% | -11.0% | +3.3% | +44.3% | +7.4% | -22.7% | -13.8% | -3.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 4.3% | 5.7% | 27.2% | 48.2% | 40.8% | 26.8% | 8.9% | -8.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 22.6% | 18.8% | 52.5% | 68.0% | 52.0% | 30.1% | 9.1% | -8.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.8% | 0.9% | 5.3% | 10.4% | 10.2% | 8.2% | 2.6% | -2.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.8% | 1.0% | 6.2% | 12.2% | 12.0% | 9.7% | 3.1% | -2.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 4.3 | 2.3 | 0.9 | 0.4 | 0.3 | 0.1 | 0.0 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 70,996 | 59,734 | 67,570 | 90,510 | 86,664 | 77,290 | 70,637 | 74,556 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Unimeda - Social security debts
The company had no debts to Sodra
Unimeda - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Unimeda, UAB (code 235499230) is a Private Limited Liability Company engaged in the wholesale of paper rolls and paperboard. In 2025, the company generated revenue of EUR 944.4K, down 3.4% year on year and 16.7% below the 2023 level. Profitability weakened over the period: net profit fell from EUR 93.4K in 2023 to EUR 25.6K in 2024, before turning into a net loss of EUR 20.9K in 2025, with a profit margin of -2.2%. The balance sheet remained relatively conservative, with total assets of EUR 259.3K and equity of EUR 234.5K at the end of 2025. Liabilities were EUR 24.8K, resulting in a debt-to-equity ratio of 0.11 and an equity ratio of 90.4%. Asset turnover stood at 3.64x, indicating efficient use of the asset base relative to revenue. Productivity metrics also reflected the decline in earnings, with revenue per employee at EUR 78.7K and profit per employee at -EUR 1.7K in 2025.